Integral Health Asset Management, LLC Denali Therapeutics Inc. Transaction History
Integral Health Asset Management, LLC
- $1.04 Billion
- Q2 2024
A detailed history of Integral Health Asset Management, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 325,000 shares of DNLI stock, worth $8.73 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
325,000Holding current value
$8.73 Million% of portfolio
0.73%Shares
13 transactions
Others Institutions Holding DNLI
# of Institutions
216Shares Held
115MCall Options Held
127KPut Options Held
38.3K-
Baillie Gifford & CO13.8MShares$370 Million0.25% of portfolio
-
Black Rock Inc. New York, NY13.2MShares$354 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$304 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.82MShares$264 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.13MShares$191 Million0.04% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $3.6B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...